Heparin Sodium Injection, USP is a sterile solution of heparin sodium derived from porcine intestinal mucosa, standardized for use as an anticoagulant It is to be administered by intravenous or subcutaneous routes Each mL contains 10,000 USP units heparin sodium, in water for injection and hydrochloric acid or sodium hydroxide for PH adjustment SDS Manufacturer # PFS5705 Manufacturer B. Braun Country of Origin Unknown Application Anticoagulant Container Type Prefilled Syringe Dosage Form Injection Generic Drug Name Heparin Sodium, Porcine, Preservative Free Product Dating McKesson Acceptable Dating: we will ship >= 90 days Strength 5,000 U / 0.5 mL Type Intravenous or Subcutaneous UNSPSC Code 51131602 Volume 0.5 mL
SKU: PFS5705
$2,950.35 $2,261.94
Excel® Flexible Plastic Bag MSDS Manufacturer # P5771 Manufacturer B. Braun Country of Origin Unknown Alternate Packaging CS/24 Application Anticoagulant Container Type Flexible Bag Dosage Form IV Solution Generic Drug Code 26423 Generic Drug Name Heparin Sodium, Porcine / 5% Dextrose, Preservative Free NDC Number 00264957710 Product Dating McKesson Acceptable Dating: we will ship >= 90 days Strength 50 U / mL Type Intravenous UNSPSC Code 51131602 Volume 500 mL
SKU: P5771
$1,160.09 $889.40
Excel® containers feature biologically inert, non-toxic plastic construction Unique PVC-Free and DEHP-Free design provides for a safe, accurate means of administering IV medication Upon incineration, Excel containers form carbon dioxide gas and water Manufacturer # P8721 Manufacturer B. Braun Country of Origin Unknown Application Anticoagulant Container Type Flexible Bag Dosage Form IV Solution Generic Drug Code 99925 Generic Drug Name Heparin Sodium, Porcine / 0.9% Sodium Chloride, Preservative Free NDC Number 00264987210 Product Dating McKesson Acceptable Dating: we will ship >= 90 days Strength 2 U / mL Type Intravenous UNSPSC Code 51131602 Volume 500 mL
OraVerse Local Anesthesia Reversal Agent. Box containing 1 blister of 10 x 1.7 OraVerse is the first and only local anesthesia reversal agent In clinical trials, the median time to recovery of normal sensation in the upper lip was 50 minutes for OraVerse patients vs. 133 minutes for the control group and in the lower lip was 70 minutes for OraVerse patients vs. 155 minutes for the control. In clinical trials, OraVerse patients were more quickly able to smile, speak, drink normally and minimize drooling. Market research shows 88% of patients may be interested in receiving a product like OraVerse1 Presentation Item #99210 – Box containing 1 blister of 10 x 1.7ml glass cartridges
SKU: 99210
$79.99 $74.99
